Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27626/">Read the article</a>

Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the Movement Disorders journal. Read the article

Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the <i>Movement Disorders</i> journal. <a href=" https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.27626/" rel="noopener noreferrer">Read the article</a>

Advanced therapies for Parkinson's disease: Are they all the same?

Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.

Share Advanced therapies for Parkinson's disease: Are they all the same?

Sign up to save your podcasts

Advanced therapies for Parkinson's disease: Are they all the same?

Advanced therapies for Parkinson's disease: Are they all the same?